Stock listing

Frankfurt:8Z1 PharmaEssentia Corp. Aktie

German listing (Frankfurt) of PharmaEssentia Corp. · home listing TWSE:6446

Follow PharmaEssentia Corp. into a list and get an email when it puts out news.

Home listing price · TWSE:6446

$1,245.00 TWD +40.00 (+3.3%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TWSE:6446

Since Jul 6, 2026 -22.3% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
$1,230.00 – $1,300.00 TWDOct 16, 2026
Volume
3.48M sharesOct 16, 2026
Market value
$515.1B TWDAt the close on Oct 16, 2026 · price × 413.7M shares outstanding
PharmaEssentia Corp. logo
Ticker
Frankfurt:8Z1
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

PharmaEssentia to Present at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting

Sep 9, 2026

FDA Approves PharmaEssentia’s BESREMi® (ropeginterferon alfa-2b-njft) for Adults with Essential Thrombocythemia, A Rare Blood Cancer

Aug 31, 2026

PharmaEssentia Announces Health Canada Approval of BESREMi(R) (ropeginterferon alfa-2b) for Polycythemia Vera (PV)

Jul 7, 2026

PharmaEssentia Announces Health Canada Approval of BESREMi® (ropeginterferon alfa-2b) for Polycythemia Vera (PV)

Jul 6, 2026

PharmaEssentia Announces FDA Approval and U.S. Launch of BESREMi Pen (ropeginterferon alfa-2b-njft) for Polycythemia Vera

Jun 29, 2026

PharmaEssentia Expands North American Commercial Footprint with Acquisition of Canadian Partner FORUS Therapeutics

Jun 11, 2026

PharmaEssentia Announces Taiwan Approval of BESREMi® for Essential Thrombocythemia, Marking First Global Approval in ET

Jun 10, 2026

PharmaEssentia Appoints Eric Vogel as U.S. Head of Commercialization Ahead of Potential Launch of BESREMi® in Essential Thrombocythemia

May 27, 2026

PharmaEssentia to Present New Clinical Data Supporting the Use of Ropeginterferon Alfa-2b in Essential Thrombocythemia at ASCO and EHA 2026

May 22, 2026

Taiwan's Representative to the United States Alexander Tah-ray Yui Visits PharmaEssentia's Puerto Rico Facility Alongside Puerto Rico Officials

Apr 27, 2026

All PharmaEssentia Corp. news

Decks

PharmaEssentia Corp. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
22 in the last 12 months · 42 in all · newest Sep 9, 2026 · oldest 2023
Decks
5 decks · latest Aug 12, 2026

Where PharmaEssentia Corp. is listed

ListingExchangeCountryCurrency
TWSE:6446 藥華藥 · Home listingTWSETaiwanTWD
Frankfurt:8Z1 · This pageFrankfurtGermanyEUR
LUXSE:PHECALUXSELuxembourgUSD
LUXSE:PHECRLUXSELuxembourgUSD

Log in to ask 6ix AI your own questions about PharmaEssentia Corp.